Patent · US Active

Ras inhibitors

US12280113B2 · kind B2 · utility

2Cited by
29References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 23, 2023
Grant dateApr 22, 2025
Priority date—
Expiry dateAug 1, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The disclosure features macrocyclic compounds, and pharmaceutical compositions and protein complexes thereof, capable of inhibiting Ras proteins, and their uses in the treatment of cancers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.